Disease Description (Causes and Symptoms)
Motor neuron disease (MND) is a group of degenerative diseases in which motor nerve cells in the brain (upper motor neurons) and spinal cord (lower motor neurons) are progressively damaged, causing muscle weakness and muscle atrophy. The main pathophysiological mechanisms are presumed to include degeneration of motor neurons (protein accumulation and aggregation, impaired axonal transport), glutamatergic excitotoxicity, oxidative stress, mitochondrial dysfunction, immune and inflammatory responses, and genetic factors (such as C9orf72 and SOD1).
Main symptoms
- Gradual muscle weakness and atrophy in the limbs (gait disturbance, frequently dropping objects)
- Muscle cramps (muscle spasms), muscle stiffness (spasticity)
- Difficulty swallowing (dysphagia), speech disorder (dysarthria)
- Shortness of breath (especially worsening at night or when lying down), weak cough
- Weight loss, fatigue
Diagnostic features include clinical findings of upper and lower motor neuron abnormalities and widespread denervation and reinnervation findings on electrophysiological testing (electromyography/nerve conduction studies). Imaging (MRI), blood tests, and, when necessary, muscle biopsy and genetic testing are performed to rule out other diseases (such as myelopathy and myopathy).
Treatment Methods (Standard Treatment, Medications, Procedures, and Lifestyle Management) and Precautions
The goals of treatment are to slow disease progression, prevent complications, and maintain quality of life. Curative treatment is currently limited.
Medication treatment
- Riluzole: A standard medication known to extend survival by several months (generally 50 mg twice daily). Liver function monitoring is required.
- Edaravone (such as Radicava): Shows an effect in slowing the rate of functional decline in some patient groups (administered intravenously in standardized cycles). Indications and effectiveness vary according to national guidelines.
- Symptom-relief medications: For muscle spasticity (baclofen, tizanidine), excessive salivation (glycopyrrolate, botulinum toxin), neuropathic pain/depression (tricyclic antidepressants or SSRIs, etc.), and symptomatic treatment for constipation and sleep disorders.
Respiratory, nutritional, and rehabilitative treatment
- Respiratory management: Regular follow-up with pulmonary function tests (FVC), nocturnal intermittent respiratory assessments, and inspiratory pressure measurements. Noninvasive positive-pressure ventilation (NIV, BiPAP) is recommended in cases of hypoxia or hypercapnia. Mechanical ventilation and tracheostomy are determined by considering the patient’s preferences and prognosis.
- Intake and nutrition: In cases of difficulty swallowing, nutritional support methods such as PEG (percutaneous endoscopic gastrostomy) may be considered after a swallowing evaluation.
- Rehabilitation: Physical therapy, occupational therapy, and speech therapy (swallowing training), as well as the use of assistive devices (walkers, wheelchairs), are recommended.
- Multidisciplinary approach: Integrated management by neurology, respiratory medicine, nutrition, swimming techniques, rehabilitation, mental health, and palliative care teams is beneficial for prognosis and quality of life.
Surgery/procedures
- PEG placement (nutritional support), tracheostomy (selective)
- Botulinum toxin (used to reduce salivation as an invasive procedure)
Precautions (self-management and prevention of complications)
- Regular respiratory function tests and swallowing evaluations should be performed.
- Monitoring such as liver enzyme and blood tests is necessary when taking medications, especially riluzole.
- Prevention of pneumonia (aspiration pneumonia): oral hygiene, adjustment of eating posture and food consistency, and consideration of PEG when necessary.
- Prevention of pressure sores and fractures caused by falls and muscle atrophy (positioning and skin care).
- Seek medical attention promptly if breathing worsens or an acute infection develops.
- Advance discussion of end-of-life care and decisions about life-sustaining treatment (preferences regarding life-sustaining treatment) is recommended.
Prognosis
- Average survival is several years after diagnosis (generally 3–5 years), but there is considerable individual variation. Approximately 20% of all patients survive for more than 5 years after diagnosis.
Checklist Before an Outpatient Visit (Including Items to Prepare and Example Questions)
Items/documents to bring
- A list of all currently taken medications and supplements (including dosage and frequency)
- Copies of previous test results (EMG, MRI, blood tests, respiratory tests, etc.)
- Records of recent weight changes (weight log)
- Symptom records (when and in what situations symptoms worsen, changes in swallowing, breathing, speech, etc.)
- Caregiver contact information and information about the ability to perform daily activities (level of independence)
Information to tell the doctor in advance during the outpatient visit
- Recent worsening of shortness of breath (frequency of waking at night, symptoms of sleep apnea)
- Difficulty swallowing (choking, frequency of coughing, weight loss)
- Newly developed muscle weakness or inability to walk
- Symptoms suspected to be medication side effects (nausea, jaundice, fatigue, etc.)
Items that are useful to record
- Patterns of fatigue and weakness during the day (by time of day)
- Amount of food intake and situations that occur when swallowing is difficult
- Respiratory symptoms (cough strength, amount of secretions)
- History of falls and injuries
General Example Questions to Ask the Doctor
- How is the progression of this disease expected to proceed in my case? What are the main factors used to assess the prognosis?
- Why do you recommend riluzole (or edaravone), and what are the expected benefits and side effects?
- What tests should I undergo and when should they begin if my respiratory function starts to decline? When should noninvasive ventilation be started?
- When is nutritional management (PEG) recommended, and what are its advantages and disadvantages?
- What rehabilitation methods and assistive devices can help with daily life, and where can I obtain them?
Examples of Disease-Specific Questions (1–2)
- Is it possible that my disease has a genetic cause? Do you recommend genetic testing (for example, C9orf72 or SOD1)—if the results are important for family planning, how should they be interpreted?
- Recently, I have been short of breath and waking frequently at night or when lying down. When should noninvasive ventilation (NIV) be started? What benefits and lifestyle changes can be expected after starting NIV?
References (Key Summary of Diagnosis and Management)
- Diagnosis: Confirm involvement of upper and lower motor neurons through clinical findings and electromyography (EMG), rule out other causes with MRI, and perform genetic testing when necessary.
- Treatment: Riluzole (prolongs survival), edaravone (selective indications), multidisciplinary supportive treatment centered on respiratory, nutritional, and rehabilitation care, and symptom treatment (spasticity, salivation, pain, etc.).
- Complications: Respiratory failure, aspiration pneumonia, malnutrition, pressure sores and thrombosis, depression and anxiety.